Cargando…
Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies
Cisplatin is one of the most widely used and highly effective drug for the treatment of various solid tumors; however, it has dose-dependent side effects on the kidney, cochlear, and nerves. Nephrotoxicity is the most well-known and clinically important toxicity. Numerous studies have demonstrated t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte Metabolism
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297704/ https://www.ncbi.nlm.nih.gov/pubmed/25606044 http://dx.doi.org/10.5049/EBP.2014.12.2.55 |
_version_ | 1782353174036742144 |
---|---|
author | Oh, Gi-Su Kim, Hyung-Jin Shen, AiHua Lee, Su Bin Khadka, Dipendra Pandit, Arpana So, Hong-Seob |
author_facet | Oh, Gi-Su Kim, Hyung-Jin Shen, AiHua Lee, Su Bin Khadka, Dipendra Pandit, Arpana So, Hong-Seob |
author_sort | Oh, Gi-Su |
collection | PubMed |
description | Cisplatin is one of the most widely used and highly effective drug for the treatment of various solid tumors; however, it has dose-dependent side effects on the kidney, cochlear, and nerves. Nephrotoxicity is the most well-known and clinically important toxicity. Numerous studies have demonstrated that several mechanisms, including oxidative stress, DNA damage, and inflammatory responses, are closely associated with cisplatin-induced nephrotoxicity. Even though the establishment of cisplatin-induced nephrotoxicity can be alleviated by diuretics and pre-hydration of patients, the prevalence of cisplatin nephrotoxicity is still high, occurring in approximately one-third of patients who have undergone cisplatin therapy. Therefore it is imperative to develop treatments that will ameliorate cisplatin-nephrotoxicity. In this review, we discuss the mechanisms of cisplatin-induced renal toxicity and the new strategies for protecting the kidneys from the toxic effects without lowering the tumoricidal activity. |
format | Online Article Text |
id | pubmed-4297704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | The Korean Society of Electrolyte Metabolism |
record_format | MEDLINE/PubMed |
spelling | pubmed-42977042015-01-20 Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies Oh, Gi-Su Kim, Hyung-Jin Shen, AiHua Lee, Su Bin Khadka, Dipendra Pandit, Arpana So, Hong-Seob Electrolyte Blood Press Review Cisplatin is one of the most widely used and highly effective drug for the treatment of various solid tumors; however, it has dose-dependent side effects on the kidney, cochlear, and nerves. Nephrotoxicity is the most well-known and clinically important toxicity. Numerous studies have demonstrated that several mechanisms, including oxidative stress, DNA damage, and inflammatory responses, are closely associated with cisplatin-induced nephrotoxicity. Even though the establishment of cisplatin-induced nephrotoxicity can be alleviated by diuretics and pre-hydration of patients, the prevalence of cisplatin nephrotoxicity is still high, occurring in approximately one-third of patients who have undergone cisplatin therapy. Therefore it is imperative to develop treatments that will ameliorate cisplatin-nephrotoxicity. In this review, we discuss the mechanisms of cisplatin-induced renal toxicity and the new strategies for protecting the kidneys from the toxic effects without lowering the tumoricidal activity. The Korean Society of Electrolyte Metabolism 2014-12 2014-12-31 /pmc/articles/PMC4297704/ /pubmed/25606044 http://dx.doi.org/10.5049/EBP.2014.12.2.55 Text en Copyright © 2014 The Korean Society of Electrolyte Metabolism http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Oh, Gi-Su Kim, Hyung-Jin Shen, AiHua Lee, Su Bin Khadka, Dipendra Pandit, Arpana So, Hong-Seob Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title | Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title_full | Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title_fullStr | Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title_full_unstemmed | Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title_short | Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies |
title_sort | cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297704/ https://www.ncbi.nlm.nih.gov/pubmed/25606044 http://dx.doi.org/10.5049/EBP.2014.12.2.55 |
work_keys_str_mv | AT ohgisu cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT kimhyungjin cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT shenaihua cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT leesubin cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT khadkadipendra cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT panditarpana cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies AT sohongseob cisplatininducedkidneydysfunctionandperspectivesonimprovingtreatmentstrategies |